India's AIOCD Ltd offers private label generics
Private label generic medicines have entered the market across India through a limited company - All Indian Origin Chemists and Distributors (AIOCD Ltd), the commercial arm of the All India Organization of Chemists and Druggists, according to a report by MyNews.In.
Taking into consideration the expected increase in demand of pharmaceuticals from the society, and in view the government to giving importance to generic medicines, pharmaceutical dealers from all over the country had asked AIOCD to bring private label' generic to the market. As a result, the company has initiated the first stage of its ambitious plan, starting with distribution in 15 states with 100 products. The product range will be increased gradually according to demand from pharmaceutical dealers.
Range to be sold through JAVA division
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Generics
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze